State of Wyoming’s Aquestive Therapeutics AQST Stock Holding History

State of Wyoming’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-753	Closed	-$3.13K	–	1898
2026 Q1	$3.13K	Buy	+753	New	+$3.06K	﹤0.01%	1756
2025 Q1	–	Sell	-5,229	Closed	-$18.6K	–	1644
2024 Q4	$18.6K	Buy	+5,229	New	+$24.1K	﹤0.01%	1524
2024 Q3	–	Sell	-13,176	Closed	-$34.3K	–	1685
2024 Q2	$34.3K	Buy	+13,176	New	+$44K	0.01%	1469

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

State of Wyoming's AQST Position: Q2 2026 in Review

State of Wyoming sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 753 shares — an estimated $3.13K sold.

State of Wyoming first reported a position in AQST in Q2 2024 and held it in 3 quarters. The position peaked at $34.3K in Q2 2024. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

State of Wyoming reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
State of Wyoming sold 753 Aquestive Therapeutics shares in Q2 2026, an estimated $3.13K.
State of Wyoming first reported a position in Aquestive Therapeutics in Q2 2024 and held it in 3 quarters.
State of Wyoming's Aquestive Therapeutics position peaked at $34.3K in Q2 2024.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.